BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Up 129.3% in December

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 153,400 shares, a growth of 129.3% from the November 30th total of 66,900 shares. Based on an average trading volume of 47,600 shares, the days-to-cover ratio is presently 3.2 days. Currently, 3.0% of the company’s stock are sold short.

BioRestorative Therapies Price Performance

Shares of NASDAQ BRTX opened at $1.55 on Friday. BioRestorative Therapies has a 1-year low of $1.03 and a 1-year high of $3.67. The business has a fifty day moving average price of $1.52 and a 200 day moving average price of $1.63. The stock has a market capitalization of $10.73 million, a P/E ratio of -1.01 and a beta of 62.52.

BioRestorative Therapies (NASDAQ:BRTX) last announced its earnings results on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.22. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. The business had revenue of $0.23 million during the quarter, compared to the consensus estimate of $0.30 million. As a group, equities research analysts anticipate that BioRestorative Therapies will post -1.43 earnings per share for the current fiscal year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.